Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.

Gridelli, C

Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature. [electronic resource] - Anticancer research - 1077-84 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Review

0250-7005


Adult
Aged
Antineoplastic Agents, Phytogenic--adverse effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Deoxycytidine--analogs & derivatives
Docetaxel
Drug Administration Schedule
Female
Granulocyte Colony-Stimulating Factor--adverse effects
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Paclitaxel--adverse effects
Survival Analysis
Taxoids
Gemcitabine